Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market
Holding NVCT?
Track your performance easily

Nuvectis Pharma (NVCT) Technical Analysis

75 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Nuvectis Pharma’s (NVCT) Moving Averages Convergence Divergence (MACD) indicator is 0.22, suggesting Nuvectis Pharma is a Buy.
Nuvectis Pharma’s (NVCT) 20-Day exponential moving average is 7.33, while Nuvectis Pharma’s (NVCT) share price is $8.15, making it a Buy.
Nuvectis Pharma’s (NVCT) 50-Day exponential moving average is 7.01, while Nuvectis Pharma’s (NVCT) share price is $8.15, making it a Buy.

Nuvectis Pharma (NVCT) Pivot Points

Nov 08, 2024, 01:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.98
5.49
6.46
6.97
7.94
8.45
9.42
Fibonacci
5.49
6.06
6.40
6.97
7.54
7.88
8.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Nuvectis Pharma (NVCT) Moving Averages

Nov 08, 2024, 01:30 AM
Period
Simple
Exponential
MA5
7.15Buy
7.48Buy
MA10
7.69Buy
7.47Buy
MA20
7.38Buy
7.33Buy
MA50
6.81Buy
7.01Buy
MA100
6.73Buy
6.92Buy
MA200
7.15Buy
7.28Buy
Nuvectis Pharma’s (NVCT) 10-Day exponential moving average is 7.47, while Nuvectis Pharma’s (NVCT) share price is $8.15, making it a Buy.
Nuvectis Pharma’s (NVCT) 100-Day exponential moving average is 6.92, while Nuvectis Pharma’s (NVCT) share price is $8.15, making it a Buy.
Nuvectis Pharma’s (NVCT) stock price is $8.15 and Nuvectis Pharma’s (NVCT) 50-day simple moving average is 6.81, creating a Buy signal.
Nuvectis Pharma’s (NVCT) stock price is $8.15 and Nuvectis Pharma’s (NVCT) 100-day simple moving average is 6.73, creating a Buy signal.
Nuvectis Pharma’s (NVCT) stock price is $8.15 and Nuvectis Pharma’s (NVCT) 200-day simple moving average is 7.15, creating a Buy signal.

Nuvectis Pharma (NVCT) Technical Indicators

Nov 08, 2024, 01:30 AM
Name
Value
Implied Action
RSI (14)
59.88
Neutral
STOCH (9,6)
38.94
Neutral
STOCHRSI (14)
38.94
Neutral
MACD (12,26)
0.22
Buy
ADX (14)
23.70
Neutral
Williams %R
-29.94
Buy
CCI (14)
44.38
Neutral
ATR (14)
0.72
-
Ultimate Oscillator
53.78
Neutral
ROC
20.56
Buy
Nuvectis Pharma’s (NVCT) Relative Strength Index (RSI) is 59.88, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Trend Strength Indicator (ADX) is 23.70, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Commodity Channel Index (CCI) is 44.38, creating a Neutral signal.
Nuvectis Pharma’s (NVCT) Price Rate of Change (ROC) is 20.56, creating a Buy signal.

FAQ

Is NVCT a Buy, Hold, or Sell?
Based on NVCT’s technical indicators, NVCT is a Strong Buy.
    What is NVCT’s RSI (14)?
    NVCT’s RSI (14) is 59.88, which suggests NVCT is a Neutral.
      What is NVCT’s MACD?
      NVCT’s MACD is 0.22, which suggests NVCT is a Buy.
        What is NVCT’s 5-day moving average?
        NVCT’s 5-day moving average is 7.15, which suggests NVCT is a Buy.
          What is NVCT’s 20-day moving average?
          NVCT 20-day moving average is 7.38, which suggests NVCT is a Buy.
            What is NVCT’s 50-day moving average?
            NVCT’s 50-day moving average is 6.81, which suggests NVCT is a Buy.
              What is NVCT’s 200-day moving average?
              NVCT’s 200-day moving average is 7.15, which suggests NVCT is a Buy.
                What is NVCT’s Williams % R (14)?
                NVCT’s Williams % R (14) is -29.94, which suggests NVCT is a Buy.
                  What is NVCT’s CCI (14)?
                  NVCT’s CCI (14) is 44.38, which suggests NVCT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis